151. Methods to monitor distribution and metabolic activity of mesenchymal stem cells following in vivo injection into nucleotomized porcine intervertebral discs.
Omlor GW, Bertram H, Kleinschmidt K, Fischer J, Brohm K, Guehring T, Anton M, Richter W
Eur Spine J. 2010 Apr .
PMID: 20039083 [PubMed - in process]
152. Steady-state cross-presentation of OVA is mannose receptor-dependent but inhibitable by collagen fragments.
Burgdorf S, Schuette V, Semmling V, Hochheiser K, Lukacs-Kornek V, Knolle PA, Kurts C
Proc Natl Acad Sci U S A. 2010 Mar 30.
PMID: 20308535 [PubMed - in process]
153. Low-dose cyclophosphamide treatment impairs regulatory T cells and unmasks AFP-specific CD4+ T-cell responses in patients with advanced HCC.
Greten TF, Ormandy LA, Fikuart A, Höchst B, Henschen S, Hörning M, Manns MP, Korangy F
J Immunother. .
PMID: 20139774 [PubMed - in process]
154. Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells.
Schurich A, Berg M, Stabenow D, Böttcher J, Kern M, Schild HJ, Kurts C, Schuette V, Burgdorf S, Diehl L, Limmer A, Knolle PA
J Immunol. 2010 Apr 15.
PMID: 20212092 [PubMed - in process]
155. Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs.
Semmling V, Lukacs-Kornek V, Thaiss CA, Quast T, Hochheiser K, Panzer U, Rossjohn J, Perlmutter P, Cao J, Godfrey DI, Savage PB, Knolle PA, Kolanus W, Förster I, Kurts C
Nat Immunol. 2010 Apr .
PMID: 20190758 [PubMed - in process]
156. Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells.
Meda C, Plank C, Mykhaylyk O, Schmidt K, Mayer B
Pharmacol Rep. .
PMID: 20360620 [PubMed - in process]
157. Avoiding spam in the proteolytic internet: future strategies for anti-metastatic MMP inhibition.
Krüger A, Kates RE, Edwards DR
Biochim Biophys Acta. 2010 Jan .
PMID: 19800374 [PubMed - in process]
158. The nuclear receptor PPAR gamma selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity.
Klotz L, Burgdorf S, Dani I, Saijo K, Flossdorf J, Hucke S, Alferink J, Nowak N, Novak N, Beyer M, Mayer G, Langhans B, Klockgether T, Waisman A, Eberl G, Schultze J, Famulok M, Kolanus W, Glass C, Kurts C, Knolle PA
J Exp Med. 2009 Sep 28.
PMID: 19737866 [PubMed - in process]
159. Therapeutic vaccination with an interleukin-2-interferon-gamma-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer: a phase I/II trial.
Brill TH, Kübler HR, Pohla H, Buchner A, Fend F, Schuster T, van Randenborgh H, Paul R, Kummer T, Plank C, Eisele B, Breul J, Hartung R, Schendel DJ, Gansbacher B
Hum Gene Ther. 2009 Dec .
PMID: 19671000 [PubMed - in process]
160. Nucleic acid delivery to magnetically-labeled cells in a 2D array and at the luminal surface of cell culture tube and their detection by MRI.
Mykhaylyk O, Steingötter A, Perea H, Aigner J, Botnar R, Plank C
J Biomed Nanotechnol. 2009 Dec .
PMID: 20201231 [PubMed - in process]